Rapid issue screen
A focused view of material pathway and execution questions before deeper work.
WHO WE HELP / INVESTORS & BOARDS
See the execution risk behind the scientific promise
VED provides independent, decision-focused review of clinical and regulatory pathways, evidence gaps, organisational capability and the practical burden of the next value inflection.
VED working method
- 01Thesis
- 02Risk
- 03Value
01
Questions we can help answer
- Is the proposed development pathway coherent and executable?
- Which regulatory assumptions are material to time, capital or probability of success?
- Are dose, population, endpoint, biomarker and comparator choices aligned?
- What evidence is genuinely decision-enabling versus merely planned?
- Does the organisation have the leadership and specialist capacity for the next phase?
- Where could a focused intervention create the greatest value over 90 days?
02
Diligence outputs
Independent programme diagnostic
Evidence review, assumption register, development scenarios and prioritised risk map.
Management challenge session
A structured discussion to test rationale, dependencies, alternatives and readiness.
100-day capability plan
The leadership, expert and operating capacity required after investment or transaction.
Start with the constraint
What must your programme decide, prove or deliver next?
Share the situation, evidence and timing. We will propose the smallest credible first step.